Immunization

CDC: Update on Influenza Activity in the U.S.

December 08, 2017

Influenza activity was low during October 2017, has been increasing since the start of November

Sanofi Discontinues <i>C. Difficile</i> Tx Development

By December 08, 2017

Data that has been collected from the trial so far will be analyzed and shared with the scientific community in due time.

Hepatitis A Vaccine Supply Constrained Due to Ongoing Outbreaks

By November 27, 2017

The demand for adult Hepatitis A vaccine has increased substantially over the past 6 month.

Impact of MenACWY Vaccine Program on Disease Incidence Examined

By November 27, 2017

Reductions in incidence suggest an impact of the MenACWY vaccine program in this age group.

ACP/CDC: Best Practice Advice for Hepatitis B Vaccination, Screening

November 21, 2017

All unvaccinated adults at risk for infection should be vaccinated; screening recommended for at-risk

New Vaccine for Hepatitis B Gets FDA Approval

By November 10, 2017

Two-dose vaccine for the prevention of hepatitis B in adults.

Vaccine for Universal Pneumococcal Disease Prevention in the Works

November 02, 2017

The researchers report that non-covalent colocalization of two classes of complementary antigens, one to prevent the colonization of the most aggressive S. pneumoniae serotypes and another to restrict virulence transition, provides complete vaccine effectiveness.

CDC: Increased Outreach Needed for Child Vaccination in Immigrant Population

October 31, 2017

The researchers found that at ages 2, 6, 18, and 36 months, children with at least 1 foreign-born parent were less likely to be up-to-date on recommended immunizations than children with two U.S.-born parents.

Influenza Oral Tablet Vaccine Shows Promise in Phase 2 Trial

By October 27, 2017

Results showed that the tablet group had a 39% reduction in clinical disease compared to placebo and a 27% reduction compared to the injectable QIV.

ACIP: New Vaccine Recommendations for Shingles Prevention

By October 25, 2017

The Committee voted that Shingrix is preferred over Zostavax for the prevention of zoster and related complications.

Influenza Vaccine Comparisons

October 25, 2017

Compare and contrast influenza vaccines currently available for the 2013-2014 flu season including indicated ages, allergies, and how supplied.

New Practice Program Doubles Vaccination Rates

October 25, 2017

The first step of the module is getting the team on board, which includes discussing concerns with medical assistants and other team members and then addressing those concerns.

FDA Approves Shingrix for Prevention of Shingles

By October 23, 2017

The use of Shingrix also decreased the overall incidence of postherpetic neuralgia (PHN).

Vaccination Schedule: HIV-Infected Adults

October 23, 2017

Vaccination schedule for HIV-infected adults.

Leprosy Vaccine Candidate to Be Tested in Humans

By October 12, 2017

Leprosy (also known as Hansen's disease) is caused by the Mycobacterium leprae bacteria and results in disfiguration of the skin and mucous membranes as well as incurable nerve damage.

Is Post-HSIL Tx Adjuvant HPV Vaccination in HIV-Infected MSM Cost-Effective?

October 11, 2017

Adjuvant HPV vaccination could reduce anal cancer risk in HIV-infected men who have sex with men

Jail Time for Mother Who Refused to Have Son Vaccinated

October 10, 2017

Ruling is the latest round in a long-running custody fight

Live Flu Vaccine Withdrawal Not Linked to Change in Immunization Rates

October 06, 2017

Withdrawal of live attenuated influenza vaccine recommendation not linked to change in rates

Most U.S. Measles Cases Linked to Unvaccinated Patients

October 04, 2017

Failure to vaccinate, rather than vaccine performance, appears to be driving transmission

Vaccination Schedule: HIV-Infected 7-18 Years of Age

October 03, 2017

Recommended vaccination schedule for HIV-infected children 7 to 18 years old

2017 Vaccination Schedule: 0-18 Years of Age

October 03, 2017

This schedule indicates the recommended ages for routine administration of currently licensed childhood vaccines for children 0-18 years of age.

Tdap Vaccination During Pregnancy Protects Infants From Pertussis

October 02, 2017

Multivariable vaccine effectiveness estimate 77.7 percent for Tdap administered during third trimester

CDC: Factors that Influence Flu Vaccine Coverage Among Pregnant Women, HCPs

September 29, 2017

But only 53.6 percent of pregnant women received flu shot before/during pregnancy in 2016-2017

Pneumococcal Vaccine Rates Assessed by Work-Related Asthma Status

September 28, 2017

The researchers found that 42% of the estimated 12 million ever-employed adults with current asthma had received a pneumococcal vaccine. The likelihood of receiving a pneumococcal vaccine was increased for adults with work-related asthma versus those with non-work-related asthma.

ACOG Issues Statement on Safety of Flu Vaccine During Pregnancy

By September 26, 2017

"Scientifically, it is unclear why this would occur," states Mr. Brown. "In the same study, when vaccination was given either later in the first trimester or in the second or third trimester, there was no association seen with pregnancy loss or any other adverse pregnancy outcomes."

HPV Vaccination May Protect Fertility for Some Women

By September 20, 2017

The data indicated little association between vaccination in females (FR 0.98, 95% CI: 0.90, 1.08) or males (FR 1.07, 95% CI: 0.79, 1.46) and fecundability.

Does Prenatal Biologic Therapy for IBD Affect Infant Vaccine Response?

By September 18, 2017

In addition, the researchers assayed umbilical cord blood samples from 33 infants to assess the concentration of biologic agents.

Experts Concerned About Study that Links Flu Vaccine to Spontaneous Abortion

By September 14, 2017

Overall, the study points to an association between spontaneous abortion and influenza vaccination receipt in the past 28 days. This link, however, proved significant only among those vaccinated in the previous season with the pH1N1-containing vaccine.

Quadrivalent Flu Vaccine Approved for Use in 5-Year-Olds

By September 14, 2017

Data from a randomized, observer-blinded, comparator-controlled study (n=2,278) evaluating children aged 5-17 years showed that Afluria Quadrivalent vaccine was non-inferior to a comparator vaccine containing the same recommended virus strains.

FDA Committee Gives Thumbs Up to New Shingles Vaccine Shingrix

By September 13, 2017

While not bound by the Advisory Committee's recommendation, the FDA takes its guidance into consideration.